Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GNCC CAPITAL, INC.
CLARIFICATION OF JENGU PHARMA (PTY) LIMITED ACTIVITIES IN THE REPUBLIC OF SOUTH AFRICA
EFFECTIVE: NOVEMBER 16, 2019 FILED: NOVEMBER 16, 2019
1|Page
GNCC Capital, Inc. (“GNCC” or “the Company”) clarifies Jengu Pharma (Pty) Limited’s activities in the Republic of South Africa as follows:-
GNCC holds a 40% interest in Jengu Pharma (Pty) Limited (Jengu”) through Jengu Pharma Investment Holdings, Inc. The other 60% of Jengu is held directly by both Ms. Allen and Mr. Cox.
It was mutually decided that Jengu not hold a 49% interest in Future Pharma (Pty) Limited (“Future”). Ms. Allen and Mr. Cox hold a direct 50% interest in Future. The balance of 50% of Future is held by an Investment Partner of Ms. Allen and Mr. Cox.
Due to an unforeseen potential partnership dispute in Future; Jengu elected to focus its interests in the Cannabis Industry in South Africa and with zero involvement with Future.
The existing crop that is being harvested shortly now is solely the business of Future and not directly or indirectly that of Jengu. This has no effect upon either Jengu or upon GNCC as all of the costs (and potential profits) pertaining to that crop are historical and pre-dated any involvement in Future by Jengu.
To clarify, Jengu was not entitled to any potential profits from that crop nor was Jengu liable for any financial investments in said crop. We state this to clarify statements made in our Press Release dated October 16, 2019 that may have been interpreted as either Jengu or indirectly, GNCC, receiving any benefits.
Future will no longer be listed as an indirectly held subsidiary Company. We had previously reflected it as a 19.5% indirect holding.
All and any financing of Jengu was never being effected through GNCC but through third party financing. GNCC does not have the ability to finance Jengu nor is GNCC currently in a position to raise funding.
GNCC will update shareholders as to Jengu’s plans following the completion of a strategic review of the many various options currently under consideration. Jengu will not be directly nor indirectly involved in any crop planting, growing or harvesting in 2019.
GNCC CAPITAL, INC. DATED: NOVEMBER 16, 2019
Please a positive PR will go a long way ?
Thanks TFF !!!
Coming days ? Weeks ? We’re waiting !!!
We have had an extended period of time to familiarize ourselves with shareholder concerns and we recognize that we cannot "rewrite the Company's history". What we will do, is to bring our experience and our skills to drive our Company onwards and upwards. Our primary and overriding interest is that our shareholders share and embrace our passion and unwavering commitment to the unique opportunities and explosive growth afforded to ourselves in the recently legalized Cannabis Industry in South Africa. This we will discuss with our shareholders in far greater detail over the coming days and weeks.
We both ask that our Shareholders E Mail to us, all of their questions in order for ourselves as your new Directors to be in a position to publish a public document answering each and every pertinent question. Shareholders are asked to submit all of their initial questions on or before late this weekend; thereby allowing ourselves to prepare this very detailed Q & A for our shareholders as fast and accurately as is humanly possible.
Nothing Yet from the new board ?
Yes let’s hope ! Nothing YET from Jengu ? But waiting patiently !
Gobble Gobble !!
Very Interesting ! Buy all and Buy Out !
Yes correct !!
What are Bloom and Rosenthall thinking
62 billion ???
Say what
Better start pushing soon !!
GNCC CAPITAL, INC.
DISCLOSURE OF MATERIAL STOCKHOLDING
THIS FILING ONLY REFERS TO NON VOTING SHARES OF SERIES “A” CONVERTIBLE PREFERRED STOCK
ACQUISITION
REPORTING STOCKHOLDER: PREMIER DEVELOPMENT & INVESTMENT, INC.
REPORTING DATE: OCTOBER 25, 2019
STOCKHOLDER:
PREMIER EQUITY INVESTMENTS, INC. (100% CONTROLLED BY PREMIER
DEVELOPMENT & INVESTMENT, INC.)
CAPACITY:
INSIDER
NUMBER OF SHARES OF SERIES “A” CONVERTIBLE PREFERRED STOCK HELD AS AT OCTOBER 25, 2019:
1,262,983
PERCENTAGE INTEREST IN OUTSTANDING SHARES OF SERIES “A” CONVERTIBLE PREFERRED STOCK AS AT OCTOBER 25, 2019:
27.7%
NUMBER OF OUTSTANDING SHARES OF SERIES “A” CONVERTIBLE PREFERRED STOCK AS AT OCTOBER 25, 2019:
4,559,467
VOTING RIGHTS OF SHARES OF SERIES “A” CONVERTIBLE PREFERRED STOCK:
NONE
NOTES:
Premier Equity Investments, Inc. (“Premier”); a 100% controlled Corporation of Premier Development & Investment, Inc. (OTC: PDIV) acquired an amount 15,000,000,000 (Fifteen billion) restricted voting shares of Common Stock on October 23, 2019. This represented 41.78% of the outstanding Common Stock of GNCC Capital, Inc. These were acquired in a series of “off market” transactions”.
On October 25, 2019, Premier acquired an amount of 1,262,983 shares of GNCC Capital, Inc. Series “A” Convertible Preferred Stock in a series of “off market” transactions. The value is $1,262,983 (Series “A” Preferred Stock were issued at $1.00 per share) and are convertible into restricted GNCC Capital, Inc. restricted Voting Common Stock at a 50% discount to the average trading price for the preceding 5 (five) days.
This entitles Premier to convert these shares of Series “A” Convertible Preferred Stock into an amount of $2,525,966 in the value of restricted Voting shares of GNCC Capital, Inc. All and any such conversions into restricted Voting shares of GNCC Capital, Inc. is at the sole discretion of Premier; and may be converted in whole or in part and from time to time.
Premier confirms that it intends to continue increase its shareholding in GNCC Capital, Inc. Premier confirms that this may lead to a full bid for all of the outstanding shares of GNCC Capital, Inc.
ISSUER NOTE TO THIS STOCKHOLDER DISCLOSURE:
Under the OTC Markets Disclosure Rules, any shares of GNCC Capital, Inc. Stock, acquired and/or disposed of, by any Stockholder holding in excess of (or having an interest in excess of) 10% (Ten percent) of the outstanding shares of Stock, must be disclosed on a filing; and within 5 (five) days from any such acquisition and/or disposal.
As this Stockholder is an Insider, Affiliate, Officer, Director or a Control Person(s), this Stockholder Disclosure is a regulatory requirement.
GNCC Capital, Inc. is only in a position to report and disclose: Stock Issuances and “Off Market” Stock Transactions as reported by the Transfer Agent to the Company.
GNCC Capital, Inc. is obviously not in any position to know of; and to therefore report or disclose and/or publish any transactions conducted in the market by stockholders or by market participants; or to know of; and to therefore report or disclose and/or publish any transactions conducted by Clearing Firms and/or Individual Broker Dealers, either as Principals or on behalf of Clients.
This disclosure by the Stockholder is deemed to be in the interests of increased transparency and guidance to investors and to all of our
, Premier intends to be a supportive and stable shareholder given the size of Premier’s voting power in GNCC Capital, Inc.
Sorry ! 3 cups of coffee and no sleep will do it ! Pardon my many questions !
What about Jengu ?
What’s your take dgo?
Your thoughts TFF ? Seems strange and also what’s the new company’s thoughts on this ?
Stunned Silence ?
Okay what’s going on ?
TFF great info !!!
Q@A answers today ! Let’s See !!
I’m not liking the backtracking of what was already announced ? But I wait and see !!
Yes of course !! Thanks TFF !!
Anyone answer that ?
Hello ! I’m wondering as a shareholder why Biocann Pharma would not sign the deal with Lowenthall and company ! I wish all longs much success !
YahooFINANCE
GNCC Capital, Inc. - Confirmation Of Substantial Cancellation Of Issued Common Stock
PR NewswireOctober 17, 2019, 6:00 AM EDT
LAS VEGAS, Oct. 17, 2019 /PRNewswire/ -- GNCC Capital, Inc. (GNCP) ("The Company" or "GNCC") confirms that the 17 billion shares of restricted Common Stock recently issued was solely for Preferred Shareholders to vote in excess of 51% of the Company's outstanding Common Stock.
With all of their requested actions now having been enacted upon; these shareholders are more than happy to cancel their shares of Common Stock. They have indicated that the current share structure is too large and is therefore prejudicial to their own interests.
These shares will be cancelled in the next few business days, thereby effectively reducing the amount of outstanding Common Stock by some 50%.
We note that shareholders are asking about the possibility of a Share Repurchase. We would require loan funding to facilitate this and are happy to discuss this option with Jengu's Financiers. Shareholders should be aware that Jengu is financed independently of GNCC and has its own financing facilities in place.
That being said, in order to repurchase any reasonable quantity of GNCC shares at $0.0001 is impossible and that the dollar quantum available at $0.0002 is negligible. Shareholders indicating that we could repurchase stock at those prices are not being realistic. Therefore any such Share Repurchases would have to be at higher prices, costing GNCC significantly more than many shareholders believe.
As previously indicated, we may close one or more transactions that GNCC's former Executive Directors were working on; those with cash funding for GNCC; which is available.
Further to our Press Release dated October 16, 2019, we are awaiting as much input from our shareholders as possible. We reiterate our promise, namely, "We both ask that our Shareholders E Mail to us, all of their questions in order for ourselves as your new Directors to be in a position to publish a public document answering each and every pertinent question. Shareholders are asked to submit all of their initial questions on or before late this weekend; thereby allowing ourselves to prepare this very detailed Q & A for our shareholders as fast and accurately as is humanly possible."
A link to our Press Release dated October 16, 2019: https://www.otcmarkets.com/stock/GNCP/news/GNCC-Capital-Inc---Completion-Of-Pending-Transaction-And-The-First-Public-Engagement-By-The-Companys-New-Board-Of-Direct?id=243363
Forward-Looking Statements:-This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file with the OTC Markets
GNCC Capital, Inc.
@gncccapital
·
43m
GNCC Capital, Inc. (OTC: GNCP) confirms a Press Release on Thursday October 17, 2019 at 06:00 AM EST.
Interesting ! South Africa seems to be the place ! Nice introduction ! More coming soon !
Disregard
GNCC Capital, Inc. - Completion Of Company Restructuring
PRESS RELEASE PR Newswire
Oct. 3, 2019, 06:00 AM
LAS VEGAS, Oct. 3, 2019 /PRNewswire/ -- GNCC Capital, Inc. (OTC: GNCP) ("The Company" or "GNCC") advised our shareholders on September 30, 2019 that a majority of the Company's Shareholders voting in excess of 51% of the shares of the Company's outstanding Common Stock had signed a Shareholder Resolution with all of the previously announced demands now having being ratified and with immediate effect.
Following the directives of those with voting control, we confirm with immediate effect, THAT:
Ms. Nell-Mari Allen has been appointed as the Company's President and an Executive Director; and
Mr. Angelo Cox has been appointed as the Company's Chief Operating Officer and an Executive Director; and
The Company now holds a 40% interest in Jengu Pharma (Pty) Limited ("Jengu") in the Republic of South Africa ("South Africa"); and
Ms. Allen and Mr. Cox hold the balance of the shares in Jengu, being a 60% interest.
The Company is now solely in the Cannabis Sector. The Company has retained two Mining Exploration Properties as a passive investment. It is intended that these Properties will be disposed of in due course. The Company's Executive Directors will not be responding to any requests for information on the Company's remaining Mining Exploration interests. Full details are being provided on an OTC Markets filing by the Company's former Executive Directors.
All of the detailed Filings giving effect to these multiple transactions are being filed with the OTC Markets.
We reiterate that the Company's Executive Chairman, Mr. R Y Lowenthal has now formally resigned but has agreed to stay his effective resignation and will continue to serve as a Non-Executive Director for a period of no more than one month; and solely to complete the Annual Financial Statements for the Year Ended September 30, 2019; and ensure an orderly transition. Mr. N E Blom has resigned as an Executive Director and as President of the Company and will now serve as the Company's Non-Executive Chairman and as a Director.
Ms. Allen and Mr. Cox will commence with an extremely active engagement process with their shareholders from early next week and are looking forward to introducing the "new GNCC" to their shareholders; and setting out their immediate and future plans for the Company. Ms. Allen and Mr. Cox bring a wealth of knowledge and experience in the Cannabis Industry as well as unique and extraordinary immediate opportunities for the Company; due to their interests in the Cannabis Industry in South Africa.
Given this extremely material restructuring and rebranding of the Company after many years under the control of the previous Executive Directors and having formerly been in the business of Mining Exploration; both Ms. Allen and Mr. Cox have recognized the need to; and have committed to expend the next two weeks in shareholder engagement. This is to ensure that all shareholders and investors become familiar with the Company's new business operations, opportunities, Licensing and the Cannabis Industry in South Africa.
Furthermore, they intend to evaluate and possibly consummate, two other transactions in this Sector that the former Executive Directors had been negotiating.
Both Ms. Allen and Mr. Cox wish to emphasize that GNCC is now purely a Cannabis Company. Therefore they have absolutely no intention of discussing nor commenting whatsoever upon any previous business operations and/or transactions enacted by the former Management Team of GNCC.
Forward-Looking Statements: This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file with the OTC Markets Group.
View original content:https://www.prnewswire.com/news-releases/gncc-capital-inc--completion-of-company-restructuring-300930341.html
Posted by Mad Brewer in August
Post # of 152516
Jengu Pharma Investment Holding Inc, guess where Instadose-Pharma
is going into,..
Jengu Pharma
"The Jengu is a creature with origins in African mythology, legend and folklore. In particular, accounts of their existence are first recorded within the mythology, legend and folklore of the Duala, Bakweri, and other Sawa ethnic groups in Cameroon."
(Cameroon is just west of Democratic Republic of the Congo).
https://warriorsofmyth.fandom.com/wiki/Jengu
"A jengu (plural miengu) is a water spirit in the traditional beliefs of the Sawa ethnic groups of Cameroon, particularly the Duala, Bakweri, and related Sawa peoples. Among the Bakweri, the name is liengu (plural: maengu)."
https://en.wikipedia.org/wiki/Jengu
Where is Instadose,.. The DRC.
https://instadosepharma.com/page/locations
Pharma,..
Much jengu worship is related to healing and medicine, and the miengu are called upon when mainstream healing fails,
CBD oil.
On the Facebook site for Hybrid !
I found this piece on the Hybrid website !
ARTICLES / DANGERS OF ISOCYANATES
Dangers of Electronic Potting Compound Products
12/10/18
If you have an electronic device, then it is most likely the home of an electronic potting compound. Such compounds are quite common and used in all types of electronic devices that may range from simple toys up to sophisticated computer products.
What are Electronic Potting Compounds?
A potting compound for an electronic device is designed to provide the internal components with protection from various dangers that would otherwise loosen wires or disrupt the operation of the device itself. The potting compound is usually added after the internal workings of the device have been constructed, but before the outer shell has been added.
The compound itself is usually a solid or gelatinous product that fills in the spaces inside the device, along the wiring, and especially the connection points. The product itself can vary considerably from silicone to polyurethane, but the material used for the potting compound is generally inexpensive and long-lasting.
Benefits
The primary benefit of an electronic potting compound is it provides considerable durability to the device itself. Left unprotected, most electronic devices would quickly fall apart, succumbing to the dangers present in the environment such as exposure to moisture or chemicals. Or, they would fall apart due to shock, vibration, or impacts.
Most electronic devices used today would only last a short time without the proper potting compound in place. This also includes the heat generated by the device itself which over time would damage the circuits and the wiring. So, it is easy to see why most, if not all electronic devices use a potting compound that keeps the internal workings operational for a long time.
Potential Issues
However, there are a couple of issues concerning some of the materials used for potting compounds. In particular, those that are polyurethane-based contain toxic elements that present a danger to those who assemble electronic devices and even those who use them, although the danger is limited in nature.
Polyurethane contains toxic elements, including Volatile Organic Compounds (VOCs) that can harm the body, particularly the respiratory functions. Those who have asthma and other respiratory conditions are particularly vulnerable to exposure, along with young children and seniors. The danger is greatest for those who assemble such devices and those who work in the same building or facility since the toxic elements are leaked into the air.
Until recently, it was believed that once polyurethane dried and hardened, the VOCs and any other toxic components were trapped and thus were safe. Recent studies have revealed that such toxic properties leak into the atmosphere years after the compounds have hardened.
Solutions
For those who build such devices along with anyone exposed over the long-term, the solution that many manufacturers are turning to is non-toxic electronic potting compound alternatives. This means using materials that contain little to no toxic properties or stripping away the VOCs and other toxic elements from the polyurethane itself.
By using alternative potting materials, it protects not only those who construct such devices or work in the same building or facility, but those who use such devices on a daily basis. Contact Hybrid Coating Technologies today for a free quote on potting compound for your next job.
ARTICLES / DANGERS OF ISOCYANATES
INVESTOR RELATIONS
CONTACT
Copyright © Nanotech Industries International 2018. All Rights Reserved
Hybrid Coating Technologies Newsletter
4th Qtr 2017 Issue No. 3
Dear Shareholder:
I hope you are enjoying the end-of-year holidays. 2017 has been a year of building for Hybrid Coating Technologies. In particular, we have spent a tremendous amount of effort in improving our product offering and strengthening our manufacturing, quality control and delivery process here in the United States. We have also established new toll manufacturing in Europe where we hope to begin producing in the first quarter of 2018.
In 2017, we also made great strides in increasing our sales in the U.S. Our distributor, Industrial Finishes has been selling our coatings products through multiple sales channels including directly through the contractor supply retail store, White Cap. This has helped to significantly increase our sales from approximately .5 tons per month at the beginning of the year to 7 tons per month in December. These increased sales figures will be reflected in HCT’s quarterly and annual financial filings with the SEC, which it will make its best effort to submit by the end of the first quarter of 2018.
HCT is now in discussions with multiple potential new clients who plan on using our hardeners to manufacture their own coatings in the US as well as in Europe. We hope to begin selling to the first of these potential clients in the first quarter of 2018.
In regards to the company’s foam development, HCT is now in the initial stages of a joint development agreement with a European company to jointly create a new zero isocyanate semi-rigid foam for global distribution.
Lastly, HCT will have a booth at the World of Concrete trade show in Las Vegas, Nevada at the Las Vegas Convention Center from January 23-26, 2018 (booth #O40718). We are excited about the launch of several new products (see the Sneak Preview below) and coating systems that will be on display at our booth. Attending will be our Director of Marketing and Sales, Darin Nellis; our Director of Operations, Cyril Jay-Rayon; and our Senior Technical Director, Scott Kummer as well as myself. I would like to encourage all investors to come to Las Vegas and stop by our booth to meet our team during the show.
Warm wishes for a prosperous 2018!
Sincerely,
Joseph Kristul
Chairman & CEO, Hybrid Coating Technologies
World of Concrete Product Launch Sneak Preview
Decorative Terrazzo - GREEN POLYURETHANE™ EPOXY CONCRETE (GPEC™)
Description: GPEC™ is a new monolithic epoxy-urethane concrete product developed by Hybrid Coating Technologies that has many times the strength of a standard concrete and also greater strength than a polymer (urethane) concrete. Polymer concretes have become very popular for their exceptional durability over standard concrete and their ability to dry quickly. GPEC™ improves the durability of polymer concrete. In addition, whereas polymer concrete looks synthetic, GPEC™ looks like a natural concrete and it can be polished.
Standard concrete is mixed with water, which evaporates during curing. This creates hydrolysis, which often causes micro fracturing in concrete after it has cured. Micro-fracturing, in turn, demands expensive concrete repair work over the life of the concrete. Instead, applicators can use GPEC™, which will not micro-fracture due to the epoxy and urethane properties built into the product, which also dramatically increases its water and chemical resistance. The product is also low impact on human health and the environment due to its zero VOC, zero isocyanates formulation.
Applications: GPEC™ is best used for resurfacing damaged concrete or for designer overlays.
GPEC™ can repair even the most damaged concrete in any commercial or industrial applications such as warehouses, super markets, stadiums, train/bus stations, etc. It can be used to fill cracks, spalls and other voids in damaged concrete. It cures to be harder and more durable than the concrete itself and also blends in with the natural color and texture of standard concrete.
GPEC™ can also be used as a designer finish on top of a concrete substrate for a polished concrete look or as a filled or terrazzo system with aggregate mixed in. This system is often used in decorative concrete applications such as hotel lobbies, airports and other hospitality venues.
Commercial Status: GPEC™ is now in its final stage of field and independent lab property testing. The product is projected to be commercialized in the first quarter of 2018.
Probably money !
No there was a mine with tons of silver ! But I don't know what happened in the end and I was not a shareholder of this stock ! Take care and be well !